1. Home
  2. SPRC vs REVB Comparison

SPRC vs REVB Comparison

Compare SPRC & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • REVB
  • Stock Information
  • Founded
  • SPRC 2004
  • REVB 2020
  • Country
  • SPRC Israel
  • REVB United States
  • Employees
  • SPRC N/A
  • REVB N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • REVB Health Care
  • Exchange
  • SPRC Nasdaq
  • REVB Nasdaq
  • Market Cap
  • SPRC 3.1M
  • REVB 2.6M
  • IPO Year
  • SPRC N/A
  • REVB N/A
  • Fundamental
  • Price
  • SPRC $0.32
  • REVB $3.05
  • Analyst Decision
  • SPRC
  • REVB
  • Analyst Count
  • SPRC 0
  • REVB 0
  • Target Price
  • SPRC N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • SPRC 5.9M
  • REVB 39.6K
  • Earning Date
  • SPRC 02-15-2025
  • REVB 05-08-2025
  • Dividend Yield
  • SPRC N/A
  • REVB N/A
  • EPS Growth
  • SPRC N/A
  • REVB N/A
  • EPS
  • SPRC N/A
  • REVB N/A
  • Revenue
  • SPRC $1,306,000.00
  • REVB N/A
  • Revenue This Year
  • SPRC N/A
  • REVB N/A
  • Revenue Next Year
  • SPRC N/A
  • REVB N/A
  • P/E Ratio
  • SPRC N/A
  • REVB N/A
  • Revenue Growth
  • SPRC N/A
  • REVB N/A
  • 52 Week Low
  • SPRC $0.20
  • REVB $2.36
  • 52 Week High
  • SPRC $1.79
  • REVB $60.80
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 50.23
  • REVB 49.28
  • Support Level
  • SPRC $0.30
  • REVB $2.87
  • Resistance Level
  • SPRC $0.38
  • REVB $3.32
  • Average True Range (ATR)
  • SPRC 0.04
  • REVB 0.20
  • MACD
  • SPRC 0.00
  • REVB 0.02
  • Stochastic Oscillator
  • SPRC 25.77
  • REVB 47.18

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: